Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

57.53
Delayed Data
As of Jul 20
 -0.09 / -0.16%
Today’s Change
41.93
Today|||52-Week Range
63.40
+3.51%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close57.62
Today’s open57.90
Day’s range57.27 - 57.95
Volume676,967
Average volume (3 months)824,617
Market cap$8.8B
Dividend yield--
Data as of 07/20/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+43.20%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.25

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+3.71+2.38%
SGENSeattle Genetics Inc+0.14+0.26%
ALNYAlnylam Pharmaceutic...+2.05+2.61%
RDYDr.Reddy's Laborator...-0.28-0.66%
Data as of 07/20/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts